ArticleScientific reports2026
HIF3A-mediated aberrant activation of TXNIP promotes Alzheimer's disease progression.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- HIF-2α Depletion and HIF-1α Overexpression in Vulnerable Brain Regions Distinguish Alzheimer's Disease with Cerebral Amyloid Angiopathy.International journal of molecular sciences · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Oxidative stress (OS) is a hallmark of Alzheimer's disease (AD), yet the cell type-specific mechanisms remain unclear. We analyzed a single-cell RNA sequencing (scRNA-seq) dataset to assess OS-related features in AD. OS scores were calculated using multiple algorithms, and differential expression, enrichment, protein-protein interaction (PPI) network, and machine learning (ML) approaches were applied to identify key genes. Validation was performed at both bulk and single-cell levels, and functional assays were conducted to elucidate molecular mechanisms. OS activity was significantly elevated in AD, with pronounced heterogeneity across cell types. Astrocytes exhibited the highest OS activity, and their proportion was markedly reduced in AD. We identified 54 OS-upregulated genes enriched in neurodevelopment and synaptic processes. Through integrative ML, HIF3A was pinpointed as a key OS-related gene, showing high expression in astrocytes and strong correlation with OS pathways. Mechanistically, HIF3A directly bound to the TXNIP promoter, upregulated TXNIP expression, and thereby enhanced mitochondrial ROS production, impaired energy metabolism, and exacerbated OS in astrocytes. Our findings reveal that astrocytic HIF3A mediates aberrant OS responses in AD via transcriptional upregulation of TXNIP, offering insights into potential therapeutic targets to mitigate oxidative damage in AD.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.